Skip to main content

Novavax's COVID vaccine recommended by CDC for children aged 12 through 17

Novavax's protein-based Coronavirus vaccine has been recommended by the US CDC for adolescents aged 12-17 years old after receiving emergency use authorization for adults in June.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.